NIH Forward-Funding Shift Creates a Hidden Grant Capacity Crunch
March 22, 2026 · 2 min read
David Almeida
Congress gave NIH a $216 million budget increase for FY2026, bringing total funding to $47.2 billion. But a quiet shift in how NIH disburses grant money is squeezing the number of awards the agency can make — even with more dollars on the books.
The Forward-Funding Mechanism
The culprit is forward funding: disbursing an entire multi-year grant upfront rather than in annual installments. In FY2024, only 5–15% of new NIH grants used forward funding. By FY2025, that figure jumped to roughly 40%.
The math is straightforward. When NIH commits all years of a grant at once, each award consumes a larger share of the annual budget. The result: FY2025 saw 5,564 fewer grants awarded than the prior year — an 8.6% drop — with an estimated 970 fewer new grants projected for FY2026 if the trend continues.
Budget Increase Absorbed by Inflation and Mechanics
The $216 million increase amounts to just 0.5% growth — well below the 2–3% inflation rate through 2025. In real terms, NIH's purchasing power has declined. Paylines — the score thresholds needed to secure funding — are tightening at multiple institutes.
Jeremy M. Berg, former director of the National Institute of General Medical Sciences, warned that forward funding without budget increases means "even researchers doing extremely valuable work will get denied or delayed" with "few ways to improve proposals for the next round."
Adding to the strain, the Office of Management and Budget held up NIH fund releases until March 16, creating months of uncertainty about whether appropriated dollars would actually flow to researchers.
What NIH Applicants Should Do Right Now
Researchers preparing R01 or R21 submissions should expect tighter paylines and longer wait times through FY2026. Practical steps: identify NIH institutes where your work aligns with stated priorities, pursue resubmission strategies that address reviewer concerns precisely, and build parallel applications to NSF, DOD, or foundation funders. Independent investigator Brandon Schuff of the University of Providence told Chemical & Engineering News that he has shifted to pursuing private funding, calling federal grants "a pipe dream" in the current climate. Researchers navigating these shifts can find funding strategy analysis at grantedai.com.